Gender and duration of disease differentiate responses to rituximab-dexamethasone therapy in adults with immune thrombocytopenia.
about
Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)Clinical Practice Updates in the Management Of Immune Thrombocytopenia.Treatment of Children with Persistent and Chronic Idiopathic Thrombocytopenic Purpura: 4 Infusions of Rituximab and Three 4-Day Cycles of Dexamethasone.Recent advances in understanding and management of acquired thrombocytopenia.Transitioning patients with immune thrombocytopenia to second-line therapy: Challenges and best practices.Eltrombopag-based combination treatment for immune thrombocytopenia
P2860
Gender and duration of disease differentiate responses to rituximab-dexamethasone therapy in adults with immune thrombocytopenia.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Gender and duration of disease ...... with immune thrombocytopenia.
@ast
Gender and duration of disease ...... with immune thrombocytopenia.
@en
type
label
Gender and duration of disease ...... with immune thrombocytopenia.
@ast
Gender and duration of disease ...... with immune thrombocytopenia.
@en
prefLabel
Gender and duration of disease ...... with immune thrombocytopenia.
@ast
Gender and duration of disease ...... with immune thrombocytopenia.
@en
P2093
P2860
P356
P1476
Gender and duration of disease ...... with immune thrombocytopenia.
@en
P2093
Christina S Lee
Haiyu Zhang
James L Zehnder
John Chapin
P2860
P304
P356
10.1002/AJH.24434
P577
2016-05-24T00:00:00Z